Ozempic and other weight loss drugs aren't lowering health care costs yet
GLP-1 drugs like Wegovy (NVO) might help with weight loss, but they aren’t leading to lower health care costs yet, according ...
CNET on MSN9m
Thousands of Antidepressant Bottles Were Recalled Over 'Impurity' Risk: Here's More Context
The FDA recalled delayed-release capsules of duloxetine because they contain nitrosamines, which are everywhere but can be ...
Stockpickers: Bitterest pill for pharmaceutical groups to swallow
A new Alzheimer’s treatment from US firm Eli Lilly was approved for use this week by the UK drug regulator MHRA, although disappointingly for its maker, the drug won’t be available on the NHS as it ...
Investor's Business Daily on MSN29m
Obesity Drugs-Tied ResMed Edges Higher On Quarterly Beat
ResMed stock broke out early Friday after the CPAP maker broadly beat third-quarter projections, shrugging off worries popular weight-loss drugs from Novo Nordisk and Eli Lilly would hammer its top ...